These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30272587)

  • 1. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
    Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
    Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
    Chen NE; Maldonado NV; Khankaldyyan V; Shimada H; Song MM; Maurer BJ; Reynolds CP
    Mol Cancer Ther; 2016 Nov; 15(11):2653-2664. PubMed ID: 27530131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.
    Makena MR; Cho HE; Nguyen TH; Koneru B; Verlekar DU; Hindle A; Kang MH; Reynolds CP
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27447. PubMed ID: 30251395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
    Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
    Yang B; Fan L; Fang L; He Q
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
    Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
    Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
    Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N
    BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
    Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
    Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.
    Cooper JP; Reynolds CP; Cho H; Kang MH
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1178-1184. PubMed ID: 28429653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.
    Tiberio P; Cavadini E; Abolafio G; Formelli F; Appierto V
    PLoS One; 2010 Oct; 5(10):e13362. PubMed ID: 20976277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
    Maurer BJ; Kalous O; Yesair DW; Wu X; Janeba J; Maldonado V; Khankaldyyan V; Frgala T; Sun BC; McKee RT; Burgess SW; Shaw WA; Reynolds CP
    Clin Cancer Res; 2007 May; 13(10):3079-86. PubMed ID: 17505011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
    Ganeshan VR; Schor NF
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
    Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
    PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
    Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
    Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.